Indian rupee traders are assessing the near-term outlook for the currency in the New Year, after repeated intervention by the ...

The U.S. Food and Drug Administration has declined to approve Outlook Therapeutics' drug for a type of eye disease, the company said on Wednesday, marking another setback to its prolonged effort to ...

With valuations more stable and financing conditions improving, the balance between risk and return is becoming more ...

The new year could bring peace in Ukraine or war in Venezuela, as Donald Trump prepares to host a highly politicised World ...